Press release - 20/07/2026 Blood vessels guide immune cells to metastases It has long been suspected that endothelial cells play a key role in determining how the body’s immune system responds to tumors. Researchers at the DKFZ and the Medical Faculty Mannheim of Heidelberg University have now identified, in mouse studies, a specialized population of blood vessel lining endothelial cells that enable an effective immune defense against cancer metastases in the liver. https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-guide-immune-cells-metastases
EMUNO Therapeutics: the innate immune system as a new approach to cancer treatment - 29/07/2026 Activation of macrophages: a key factor in the fight against colorectal cancer The mobilisation of the body’s own immune system through immune checkpoint inhibitors has revolutionised cancer therapy. However, the majority of solid tumours are able to evade immune surveillance. These so-called 'cold' tumours contain too few immune cells to respond effectively to current immunotherapies. This is where the Freiburg-based biotech start-up EMUNO Therapeutics GmbH comes in.https://www.gesundheitsindustrie-bw.de/en/article/news/activation-macrophages-key-factor-fight-against-colorectal-cancer
Press release - 22/07/2026 The Individual Genetic Background Shapes the Evolution of Cancer Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has now demonstrated in mice that an organism’s genetic makeup significantly influences the course of cancer development. https://www.gesundheitsindustrie-bw.de/en/article/press-release/individual-genetic-background-shapes-evolution-cancer
Press release - 23/07/2026 Flabby and flexible: How Machine Learning helps to build new proteins A team of researchers from the Heidelberg Institute for Theoretical Studies and the Max Planck Institute for Polymer Research have developed a model that learns how to generate proteins whose structures are highly flexible, even with patterns that are uncommon in natural proteins. Their work, marks a step towards the goal of designing new proteins for applications in biotechnology, therapeutics and environmental research.https://www.gesundheitsindustrie-bw.de/en/article/press-release/flabby-and-flexible-how-machine-learning-helps-build-new-proteins
Event - 06/10/2026 3rd Biointelligence Congress in Stuttgart Stuttgart, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/3rd-biointelligence-congress-stuttgart-en
Press release - 22/07/2026 BioM, bioRN and ESMT Berlin join forces to create a Unified Hub for healthcare innovation in Germany BioM Biotech Cluster Development GmbH, bioRN Life Science Cluster and ESMT Berlin announced the establishment of a Unified Hub for Healthcare Innovation. Through this alliance, the two biotech cluster organizations and DEEP – Institute for Deep Tech Innovation at ESMT will collaborate strategically to reinforce Germany’s position as a leading hub for translating scientific breakthroughs into impactful healthcare solutions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biom-biorn-and-esmt-berlin-join-forces-create-unified-hub-healthcare-innovation-germany
Press release - 24/07/2026 Changes in brain state influence the readiness to form memories Most everyday moments are quickly forgotten, while others stay with us for a lifetime. How the brain determines which memories are retained and which are lost remains an open question. A neuroscience team at the University of Tübingen, has found that spontaneous fluctuations in the brain’s internal state influence how ready the memory system is to store new information. https://www.gesundheitsindustrie-bw.de/en/article/press-release/changes-brain-state-influence-readiness-form-memories
Event - 03/11/2026 - 05/11/2026 Trinational Health Tech Days 7 Strasbourg, France and online, Conference and networking event https://www.gesundheitsindustrie-bw.de/en/event/trinational-health-tech-days-7-en